secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2026-07-01T11:16:22+00:00
Accession:  0001213900-26-073983
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio enters warrant inducement; reduces exercise price to $1.40, extends maturity to Dec 2027
--------------------------------------------------------------------------------

- Holders exercise 647,112 warrants at reduced price of $1.40/share (from $1.95), generating $905,957 in cash.
- Remaining 50% of April 2024 warrants have maturity extended from June 30, 2026 to December 31, 2027.
- Warrant exercise and amendment executed via Inducement Letter and Second Amendment on June 30, 2026.
- Shares underlying warrants are registered under effective registration statement (File No. 333-279036).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390026073983/0001213900-26-073983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390026073983/ea0296624-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-073983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer